June 2025

26 June 2025

Zydus Lifesciences Interview for Vaccine Technology Center at Pune

Post-Graduate M.Sc. in Biochemistry, Biotechnology, Microbiology, Life sciences.1-6 years of hands-on experience in relevant field, preferred Vaccine, Biotech background.

26 June 2025

Interview for D.Pharm, B.Pharm, M.Pharm in Production, IPQA at Ipca Laboratories

Experience In operation and supervision of Compression, Granulation & Coating machine I.e. Fette, Glatt, Ganson, Imprinting etc.

26 June 2025

Amneal Pharma Hiring B.Pharm in OSD regulated plant

Looking for candidates with relevant experience in OSD regulated plant. RMG, FBE,FETTE, Auto coaters, Bottle Packing line with track and trace systems.

26 June 2025

Interview for M.Pharm, MSc as Trainee at Biophore

Conduct Experiments and Write Laboratory Notebooks Good Academic knowledge and Communication skills

26 June 2025

Eli Lilly Launches Mounjaro KwikPen in India to Rival Novo Nordisk Wegovy

As reported by Reuters, U.S. pharmaceutical giant Eli Lilly has launched its Mounjaro KwikPen in India, expanding its portfolio of treatments for diabetes and obesity.

26 June 2025

Lupin Launches Generic Prucalopride Tablets in U.S. for Chronic Constipation Treatment

Lupin Limited, a leading global pharmaceutical company, has announced the launch of its Prucalopride Tablets in 1 mg and 2 mg strengths in the United States, following the recent approval of its Abbreviated New Drug Application (ANDA) by the U.S. Food and Drug Administration (FDA).

26 June 2025

Sanofi’s Riliprubart earns USFDA orphan drug designation for organ transplant complication

In a promising development for transplant medicine, global healthcare leader Sanofi has announced that its investigational therapy riliprubart has received Orphan Drug Designation from the U.S. Food and Drug Administration.

26 June 2025

UCSD develops gene therapy that preserves memory in Alzheimer’s mouse models

A pioneering gene therapy engineered by researchers at the University of California San Diego (UCSD) School of Medicine demonstrates remarkable promise in halting, and potentially reversing, cognitive decline in preclinical Alzheimer’s models.

26 June 2025

Glenmark Pharmaceuticals launches TEVIMBRA® in India, boosting access to advanced Immuno-Oncology treatments

Glenmark Pharmaceuticals Ltd., a research-driven global pharmaceutical company, has announced the launch of TEVIMBRA® (tislelizumab) in India, marking its official entry into the immuno-oncology segment.

26 June 2025

A Game-Changing Wireless Implant for Personalized Chronic Pain Relief

Chronic pain is a debilitating condition that severely impacts quality of life, often leading to reliance on opioid medications with their severe side effects and addiction risks.